Myriad Genetics’ Post

About 1 in 8 men will be diagnosed with #prostatecancer during their lifetime. It's crucial for patients to understand the aggressiveness of their cancer to avoid over and undertreatment. Prolaris® testing helps personalize treatment plans by identifying if a patient is a candidate for active surveillance, or if they should pursue treatment like surgery or radiation, or a combination. At Myriad, we're committed to enhancing patient outcomes and advancing prostate cancer care. Learn more about prostate cancer with our comprehensive eBook: https://brnw.ch/21wMj6b #ProstateCancerAwarenessMonth #Biomarkers #GeneticTesting

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics